Diagnostic Medical Systems SA - Asset Resilience Ratio

Latest as of December 2025: 1.48%

Diagnostic Medical Systems SA (ALDMS) has an Asset Resilience Ratio of 1.48% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€927.00K
≈ $1.08 Million USD Cash + Short-term Investments

Total Assets

€62.52 Million
≈ $73.09 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2025)

This chart shows how Diagnostic Medical Systems SA's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Diagnostic Medical Systems SA to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Diagnostic Medical Systems SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Diagnostic Medical Systems SA.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €927.00K 1.48%
Total Liquid Assets €927.00K 1.48%

Asset Resilience Insights

  • Limited Liquidity: Diagnostic Medical Systems SA maintains only 1.48% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Diagnostic Medical Systems SA Industry Peers by Asset Resilience Ratio

Compare Diagnostic Medical Systems SA's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
GN Store Nord
CO:GN
Medical Devices -4.56%
Getein Biotech Inc
SHG:603387
Medical Devices 29.77%
Ningbo David Medical Device Co Ltd
SHE:300314
Medical Devices 6.89%
Vieworks Co. Ltd
KQ:100120
Medical Devices 7.81%
Somnomed Ltd
AU:SOM
Medical Devices 24.67%
Dynamic Medical Technologies
TWO:4138
Medical Devices 18.54%
T&R Biofab Co. Ltd
KQ:246710
Medical Devices 0.12%

Annual Asset Resilience Ratio for Diagnostic Medical Systems SA (2012–2025)

The table below shows the annual Asset Resilience Ratio data for Diagnostic Medical Systems SA.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 1.48% €927.00K
≈ $1.08 Million
€62.52 Million
≈ $73.09 Million
+0.16pp
2024-12-31 1.32% €711.00K
≈ $831.23K
€53.95 Million
≈ $63.07 Million
-0.56pp
2023-12-31 1.88% €959.00K
≈ $1.12 Million
€51.14 Million
≈ $59.79 Million
+1.12pp
2022-12-31 0.76% €409.00K
≈ $478.16K
€53.89 Million
≈ $63.01 Million
+0.76pp
2021-12-31 0.00% €-1.00K
≈ $-1.17K
€53.03 Million
≈ $62.00 Million
0.00pp
2020-12-31 0.00% €1.00K
≈ $1.17K
€45.80 Million
≈ $53.54 Million
-7.65pp
2018-12-31 7.66% €2.82 Million
≈ $3.30 Million
€36.84 Million
≈ $43.07 Million
-8.09pp
2017-12-31 15.74% €6.31 Million
≈ $7.38 Million
€40.08 Million
≈ $46.86 Million
-5.64pp
2016-12-31 21.38% €10.69 Million
≈ $12.49 Million
€49.98 Million
≈ $58.43 Million
+17.01pp
2015-12-31 4.37% €2.03 Million
≈ $2.37 Million
€46.42 Million
≈ $54.27 Million
-8.32pp
2014-12-31 12.69% €5.00 Million
≈ $5.85 Million
€39.40 Million
≈ $46.06 Million
+12.44pp
2013-12-31 0.25% €59.00K
≈ $68.98K
€23.57 Million
≈ $27.55 Million
-6.45pp
2012-12-31 6.70% €1.55 Million
≈ $1.81 Million
€23.16 Million
≈ $27.07 Million
--
pp = percentage points

About Diagnostic Medical Systems SA

PA:ALDMS France Medical Devices
Market Cap
$33.18 Million
€28.38 Million EUR
Market Cap Rank
#23397 Global
#368 in France
Share Price
€1.10
Change (1 day)
+0.46%
52-Week Range
€1.04 - €1.47
All Time High
€2.70
About

Diagnostic Medical Systems S.A. engages in the design, development, manufacture, and sale of medical imaging systems in France. It offers ADAM, in-house software suite; R and F solutions; bone densitometry; chest and bone room; mobile; c-arm; retrofit kit; and mammography equipment. The company was founded in 1979 and is headquartered in Gallargues-le-Montueux, France.